TxFlow Level Up: trade perps and earn up to 300 USDC at $4M volume. Until Nov 2 Join
Settings8H · net · $10k
LanguageThe language of the site
ThemeDark, or a soft blue-grey
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG130.16−0.0089get 0.0011% / 1h9m 48s$187K$499K10xLong Deribit
SHORT130.94+0.0220get 0.0028% / 1h9m 48s$11K$121K10xShort Injective
Price gap+0.600%
Funding gap+0.0309% /8h

Both sides work: funding pays +$9 a day on $10k, and the gap is 0.540% above its 7d average: +$54 more if it goes back.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding+$17+0.0309% /8h now · paid +0.171% over the last 7D
Price+$54spread +0.600% now, avg +0.061% → +0.540% if it goes back
Costsdoesn’t fit$10k a leg is deeper than the books hold
Result, before costs+$71+0.71%no pointscosts unknown: book too thin at $10k · What the last 7D really paid, hour by hour → backtest

The current funding rate is far above what this pair has been paying: over the last 7 days it paid +0.171% in total, about +0.0082%/8h on average.

Price and funding

1h · history
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now+0.600%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

ORCL on 33 exchanges

lowest funding first

Before you open

2 ok · 3 to watch
  • Problem: Doesn’t fit the books—
    $10k a leg is deeper than Injective’s order book right now.
  • Note: Margin at max leverage$1,000 + $1,000
    Deribit 10x, Injective 10x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • OK: Same payment interval1h / 1h
    Both legs pay at the same time.
    Next 24h at the current rates, on $10k a leg: +$9.26Long Deribit: 24 payments, +$2.66; short Injective: 24 payments, +$6.60.
  • OK: Entry gap works for you+0.600% vs +0.061%
    You short the dearer leg. If the gap goes back to average, the short gains.
  • Watch: Short leg is thinner$11K vs $187K OI
    Injective sets your exit cost. Check its book before closing.
  • Note: No points program—
    Neither exchange runs points right now.
  • Watch: KYCDeribit Yes · Injective No
    ID, proof of address and a financial profile before any deposit; not for the US, Canada, Japan or retail UK clients.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned+0.0082%/8h × 21 periods+$17.13
Price spread+0.600% → +0.061% (7d avg)+$53.95
Slippage, 4 ordersdoesn’t fit the book at $10k—
Fee Deribit bp × 2 orders−$7.00
Fee Injective bp × 2 orders−$0.02
Net · 7 days · $10k—
doesn’t fit the books at $10k
Costs to cover—Break-even—
Slippage: Deribit: live order book, 12 min ago; Injective: live order book, 38 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGDeribit0.7716.2 bp−$1622.2 bp−$222doesn’t fitdoesn’t fit
SELL · SHORTInjective370.34doesn’t fitdoesn’t fitdoesn’t fitdoesn’t fit

Closing costs about the same again.

Alert

ORCL news

posts that mention ORCL or Oracle, from every exchangeSearch all news →
10-30 09:30GateOther🏁 Ever wondered what it takes to build a winning F1 team? We're taking Racing the Future Vol.5 straight to @redbullracing's home turf. Get ready for an exclusive look inside the Oracle Red Bull Racing F1 HQ in UK on November 9. Not just watching the race. Getting closer to what makes it happen. 🏎️ @Gate on X ↗
10-29 18:01Vest MarketsOtherOn today's session, $ORCL is down around 5%, a day after a 10.7% rally on its Investor Day. Oracle set FY30 targets of $225B+ in revenue, a 40%+ non-GAAP operating margin and $21+ in non-GAAP EPS, with free cash flow turning positive in 2H FY28. $ORCL also capped additional capital raises through FY30 at $20B, split between $10B in equity and $10B in debt, alongside a $30B+ free cash flow target for FY29. @VestExchange on X ↗
10-28 19:02Polymarket PerpsOtherGo long or short ORCL on Polymarket Perps👇 @Poly_Perps on X ↗
10-28 19:01Polymarket PerpsOtherBREAKING: Oracle shares surge nearly 12% as the company's Investor Day fuels excitement over its booming AI cloud business. @Poly_Perps on X ↗
10-28 06:35tradeXYZOtherRELIANCE references 1 equity share of Reliance Industries Limited (NSE: RELIANCE). The oracle converts the INR share price to USD at the prevailing USD/INR FX rate. Reliance Industries operates energy, petrochemicals, retail, and digital services businesses. @tradexyz on X ↗
10-27 16:55KalshiOtherJUST IN: Oracle to offer Google TPUs in its cloud for the first time @Kalshi on X ↗